0001493152-26-046112.txt : 20261007 0001493152-26-046112.hdr.sgml : 20261007 20261007144855 ACCESSION NUMBER: 0001493152-26-046112 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20261007 DATE AS OF CHANGE: 20261007 EFFECTIVENESS DATE: 20261007 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Anvion Bio, Inc. CENTRAL INDEX KEY: 0002158000 ORGANIZATION NAME: EIN: 422641266 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-600314 FILM NUMBER: 261446671 BUSINESS ADDRESS: STREET 1: 6191 CORNERSTONE COURT E., SUITE 109 CITY: SAN DIEGO STATE: CA BUSINESS PHONE: (858) 784-1790 MAIL ADDRESS: STREET 1: 6191 CORNERSTONE COURT E., SUITE 109 CITY: SAN DIEGO STATE: CA D 1 primary_doc.xml X0708 D LIVE 0002158000 Anvion Bio, Inc. 6191 CORNERSTONE COURT E. SUITE 109 SAN DIEGO CA CALIFORNIA 92121 858-784-1790 DELAWARE None None Corporation true 2026 Larry Braga 6191 Cornerstone Court E. Suite 109 San Diego CA CALIFORNIA 92121 Executive Officer Director Chief Executive Officer and Secretary Kevin Ernst 6191 Cornerstone Court E. Suite 109 San Diego CA CALIFORNIA 92121 Executive Officer Director Chief Financial Officer Anastasia Bodan 6191 Cornerstone Court E. Suite 109 San Diego CA CALIFORNIA 92121 Director Pharmaceuticals Decline to Disclose 06b false 2026-09-22 false true false 0 1000000 100000 900000 false 1 0 0 0 false Anvion Bio, Inc. /s/ Larry Braga Larry Braga Chief Executive Officer 2026-10-07